PIN1 CLINICAL AND ECONOMIC IMPACT OF INTRODUCING A QUADRIVALENT (6, 11, 16, 18) HUMAN PAPILLOMAVIRUS VACCINE IN SWITZERLAND
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63503-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)63503-6/fulltext
Title :
PIN1 CLINICAL AND ECONOMIC IMPACT OF INTRODUCING A QUADRIVALENT (6, 11, 16, 18) HUMAN PAPILLOMAVIRUS VACCINE IN SWITZERLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63503-6&doi=10.1016/S1098-3015(10)63503-6
First page :
Section Title :
Open access? :
No
Section Order :
354